Heart rate

Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug

Retrieved on: 
Thursday, May 5, 2022
Odyssey, Private Securities Litigation Reform Act, Brain, Vital signs, Twitter, Woman, Blood pressure, Oxidative stress, GLOBE, Man, Company, Biotechnology, Concussion, CA, Patient, Enrollment, Acquisition, FDA, Inflammation, OTC Markets Group, Anxiety, Neurosteroid, Contract research organization, ECG, Traffic barrier, Spirometry, CEO, News, Technology, Amnesia, Pathology, Heart rate, Pharmaceutical industry, Medical imaging

Odysseys trial is administering PRV-002, their novel drug to treat concussion, to healthy human subjects.

Key Points: 
  • Odysseys trial is administering PRV-002, their novel drug to treat concussion, to healthy human subjects.
  • Based on our animal data and after reviewing our initial Phase I trial safety reports we are optimistic that PRV-002 will be a safe option for the treatment of concussion.
  • We look forward to completing the Phase I trial and presenting our findings to the FDA.
  • Following FDA review we intend to initiate a Phase II clinical trial in the US starting with our military.

Rockley Photonics Announces Shipment of VitalSpex™ Pro Biosensing Technology for Alcohol, Lactate, and Glucose Measurement

Retrieved on: 
Wednesday, May 4, 2022
Software, Biotechnology, Networks, Health, Medical Devices, Data Management, Technology, Mobile, Wireless, COVID-19, PRO, Privacy, U.S. Securities and Exchange Commission, Forward-looking statement, Private Securities Litigation Reform Act, University, Blood pressure, Liver disease, Algorithm, Company, NYSE, Medicine, Respiratory rate, University of California, Institute for Prediction Technology, Biomarker, Contract, Security (finance), Glucose, PIC, Annual report, Diabetes, Compliance, 100,000, Health, Intellectual property, Goal, Solution, Technology, AI, Hypertension, Heart rate, Medical imaging, Risk management, Rockley

Rockley Photonics Holdings Limited (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced it has shipped its VitalSpex Pro technology for the non-invasive measurement of alcohol, glucose, and lactate to an early-access, tier-1 consumer wearables customer.

Key Points: 
  • Rockley Photonics Holdings Limited (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced it has shipped its VitalSpex Pro technology for the non-invasive measurement of alcohol, glucose, and lactate to an early-access, tier-1 consumer wearables customer.
  • The shipment of this advanced biomarker-sensing technology marks an important milestone in the progress of next-generation digital healthcare.
  • Shipping the enhanced, higher-performance Pro version of our VitalSpex biosensing platform is an important step forward for the future of the digital health category, said Dr. Andrew Rickman, chairman and chief executive officer of Rockley.
  • The Company plans to begin production of the Pro version of its VitalSpex biosensing platform in 2023, which will measure an extended range of biomarkers, including alcohol, glucose, and lactate.

Drive to earn - A new breakthrough trend

Retrieved on: 
Wednesday, May 4, 2022
Walking, Marketplace, GLOBE, NFT, Jogging, Climate change, Health, Non-fungible token, Sneakers, ROI, Bay, GPS, Uber, Exercise, Heart rate, Taxicab, Cryptocurrency, Ridesharing company, Mobile phone, Running, Drive, Gyroscope

MovingOn Finance - is a web3 mobile application that integrates Move-To-Earn mechanism through activities: Walking, Running, Cycling and Driving. MovingOn is a method of health training, based on that, users can earn corresponding profits. That is the contemporary trend --> Move-To-Earn. Users can own their favorite NFTs to move outdoors to earn profits with MOVON tokens.

Key Points: 
  • That's because the MovingOn Finance project has integrated the Drive To Earn feature in addition to other features such as Walk To Earn, Cycle To Earn, Run To Earn.
  • With a clear vision, The developers promise to make MovingOn Finance the leading project of Drive To Earn, making the impossible possible.
  • That's because the MovingOn Finance project has integrated the Drive To Earn feature in addition to other features such as Walk To Earn, Cycle To Earn, Run To Earn.
  • By walking, jogging, running, cycling, driving, users will earn currency and use in game or withdraw fiat to earn profit.

The Worldwide Implantable Defibrillators Industry is Expected to Reach $5.6 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 4, 2022
Medical Devices, Health, Atrial fibrillation, Arrhythmia, Insurance, MRI, Infarction, Ventricular tachycardia, Ventricular fibrillation, Implantable cardioverter-defibrillator, Abdomen, ICD, Patient, Electrode, Incidence, ICDS, History, Skin, Arrest, Magnetic resonance imaging, Palpitations, CAGR, SCA, Boston Scientific, Technology, Heart, Growth, Ventricular septal defect, Heart rate, Medical device

The "Implantable Defibrillators Market: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Implantable Defibrillators Market: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global implantable defibrillators market was valued at $3,300.00 million in 2020, and is projected to reach $5,612.62 million by 2030, registering a CAGR of 5.3% from 2021 to 2030.
  • Implantable defibrillators are battery-powered small devices placed underneath the chest or abdomen to keep track of a patient's heart rate.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market

Vivalink Announces World's First Multi-Vital Blood Pressure Patch for Remote Patient Monitoring

Retrieved on: 
Tuesday, May 3, 2022
Sleep, ISO, Blood pressure, Water, Algorithm, Respiratory rate, Hemodynamics, FDA, CE, Diagnosis, NMPA, ECG, Memory, CEO, Research, AI, Hypertension, Multimedia, Heart rate, Medical device, Medical imaging

CAMPBELL, Calif., May 3, 2022 /PRNewswire/ -- Vivalink, a leading provider of digital healthcare solutions, announces availability of the world's first multi-vital blood pressure patch for remote patient monitoring for use in commercial research and development. The advanced multimodal continuous signal processing patch uses electrical signal-based technologies to capture ECG trace, heart rate, respiratory rate, systolic and diastolic blood pressure on a single device. The device is FDA/NMPA cleared for ECG and heart rate, and CE cleared for ECG, heart rate and respiratory rate. The blood pressure feature is integrated and available for research and development. Weighing just 7.5 grams and the size of a small bandage, the reusable and rechargeable wearable patch requires no additional components such as a wristband or wires in order to capture blood pressure.

Key Points: 
  • CAMPBELL, Calif., May 3, 2022 /PRNewswire/ -- Vivalink , a leading provider of digital healthcare solutions, announces availability of the world's first multi-vital blood pressure patch for remote patient monitoring for use in commercial research and development.
  • The advanced multimodal continuous signal processing patch uses electrical signal-based technologies to capture ECG trace, heart rate, respiratory rate, systolic and diastolic blood pressure on a single device.
  • Key benefits of the blood pressure feature include automated readings of systolic and diastolic pressure.
  • "This milestone further establishes Vivalink as a leader and innovator in the remote patient monitoring market."

Anelto Taps GoodRx to Arm Seniors with Educational Health Videos

Retrieved on: 
Monday, May 2, 2022
Data Management, Technology, Consumer, Other Health, Mobile, Wireless, Pharmaceutical, Hospitals, Audio, Video, Other Education, Nursing, Education, Health, Practice Management, Other Technology, Seniors, Telecommunications, Managed Care, Software, General Health, Networks, Internet, Hardware, Arm, Population, Medicare, PERS, Private Securities Litigation Reform Act, Solution, Vital signs, Health care, Blood pressure, Â, Statistics, Patient, Medical alarm, Temperature, Digital, GoodRx, Overalls, Hospital, Health, Human, Mark (given name), Remote patient monitoring, Ageing, SEC, Technology, Pharmacist, RPM, Acquisition, Heart rate, Health insurance

Now, educational videos from GoodRx are also available at the touch of a button so patients can better understand complicated health topics.

Key Points: 
  • Now, educational videos from GoodRx are also available at the touch of a button so patients can better understand complicated health topics.
  • By partnering with GoodRx to deliver a series of short-form, easy-to-consume videos from within the RemoteCareLive!
  • system, we are bridging a current gap to ensure seniors become more educated about the actions they can take to improve their overall health.
  • This new integration puts GoodRx videos within reach for remote monitoring patients so they can quickly find and understand the information they need.

Impulse Dynamics Launches Optimizer Smart Mini CCM Delivery System

Retrieved on: 
Friday, April 29, 2022
Rhea, Cyclic permutation, Heart failure, LinkedIn, CE marking, Patient, Twitter, FDA, GLOBE, NYHA, Technology, Heart rate, Quality of life, Children's Mercy Hospital, Longevity, CCM, HF, Heart, CRT, University, Population, University of Kansas Medical Center, KUMC, Electrophysiology, Medical device, Pharmaceutical industry, Facebook

MARLTON, N.J., April 29, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce today both FDA and CE Mark approval and the official commercial launch of the Optimizer Smart Mini CCM therapy delivery system.

Key Points: 
  • MARLTON, N.J., April 29, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce today both FDA and CE Mark approval and the official commercial launch of the Optimizer Smart Mini CCM therapy delivery system.
  • Weve had a lot of experience with CCM using the Optimizer Smart device, but the next generation Optimizer Smart Mini CCM is simpler to implant and more comfortable for patients.
  • The Optimizer Smart Mini is a major advance for CCM therapy.
  • The Optimizer Smart Mini delivers CCM therapy the companys proprietary technology to the heart.

Global Smart Agriculture Market Outlook to 2027 - Featuring Ag Junction, Trimble and AG Leader Technology Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 28, 2022
Forest Products, Agriculture, Natural Resources, Soil, Software, Farmer, Water, Aquaculture, RFID, Water quality, Food, Livestock, COVID-19, Pressure regulator, Automation, Heart rate, Technology, Animal, Light, European Commission, CO2, Humidity, Adoption, Element, Cattle, PH, IOT, Transport, CAGR, Temperature, Hardness, Lists of countries and territories, Blood pressure, Population, FAO, Government, Health, Agriculture

The global smart agriculture market includes precision agriculture market, precision livestock monitoring market, precision aquaculture market, smart greenhouse market & precision forestry market.

Key Points: 
  • The global smart agriculture market includes precision agriculture market, precision livestock monitoring market, precision aquaculture market, smart greenhouse market & precision forestry market.
  • Precision agriculture is a method of increasing average yields by using exact amounts of inputs in comparison to traditional gardening approaches.
  • The smart greenhouse remote monitoring system primarily measures indoor CO2, humidity, temperature, light, soil moisture, soil pH, and air pressure.
  • North America is the leader in the global smart agriculture market.

HeartCloud, Inc. Raises $1.5 Million Seed Round For Its Newly Developed At-home Healthcare Software

Retrieved on: 
Thursday, April 28, 2022
CEO, Patient, FDA, Heart rate, Federation, LOS, Apple Watch, RPM, Physician, Blood pressure, Health, Prescription, Alliance for Heart Failure, Medicare, Video game, Pharmaceutical industry, Medical device, JD, MD

LOS ANGELES, April 28, 2022 /PRNewswire-PRWeb/ -- HeartCloud, Inc., an emerging digital health company, has successfully closed a seed round of 1.5 million USD as of March 31, 2022. The raise was sourced and led by Roaring Fork Capital's healthcare group based in Oklahoma City, OK (roaringforkcap.com).

Key Points: 
  • HeartCloud, Inc., an emerging digital health company, has successfully closed a seed round of 1.5 million USD as of March 31, 2022.
  • The raise was sourced and led by Roaring Fork Capital's healthcare group based in Oklahoma City, OK.
    LOS ANGELES, April 28, 2022 /PRNewswire-PRWeb/ -- HeartCloud, Inc., an emerging digital health company, has successfully closed a seed round of 1.5 million USD as of March 31, 2022.
  • The raise was sourced and led by Roaring Fork Capital's healthcare group based in Oklahoma City, OK ( roaringforkcap.com ).
  • For more information, visit heartcloud.io to learn more about its patient-focused software, and practices.heartcloud.io to learn more about its clinician-focused software.

Perry County Schools Purchases Draganfly Health Screening, Safety and Security System

Retrieved on: 
Wednesday, April 27, 2022
CSE, CEO, COVID-19, Superintendent, Software, NASDAQ, Oxygen saturation (medicine), Heart rate, Respiratory rate, Organization, GLOBE, FSE, Infection, Privacy, Technology, Student, Temperature, Agriculture, Mining, Solution, AI, Safety, United States Department of Education, Blood pressure, Public health, Education, School, U.S. Department of Defense Strategy for Operating in Cyberspace, Health, Vaccine, Hospital, Perry County School District (Mississippi)

Los Angeles, CA., April 27, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (Draganfly or the Company), an award-winning, industry-leading drone solutions and systems developer, announced today that the Companys Vital Intelligence Smart Vital Kiosks have been implemented in Perry County, Alabama by the Perry County School District (Perry County Schools).

Key Points: 
  • Los Angeles, CA., April 27, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (Draganfly or the Company), an award-winning, industry-leading drone solutions and systems developer, announced today that the Companys Vital Intelligence Smart Vital Kiosks have been implemented in Perry County, Alabama by the Perry County School District (Perry County Schools).
  • Perry County Schools is a public school district serving students from pre-kindergarten to grade 12.
  • Draganfly has installed the Companys Smart Vital Kiosks, which can provide health screening for students and staff.
  • Our main focus is the health, well-being and safety of our students, staff and community, said Dr. Marcia Smiley, Superintendent of Perry County Schools.